Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
The Efficacy and Safety of Subcutaneous...
Conference

The Efficacy and Safety of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA at Week 97 (SUMMACTA)

Authors

Cividino A; Rubbert-Roth A; Cantagrel A; Hall S; Leszczynski P; Feldman D; Rangaraj M; Roane G; Ludivico C; Mysler E

Volume

42

Pagination

pp. 1285-1285

Publisher

J RHEUMATOL PUBL CO

Publication Date

July 1, 2015

Name of conference

70th Annual Meeting of the Canadian-Rheumatology-Association (CRA)

Conference place

Quebec, CANADA

Conference start date

February 4, 2015

Conference end date

February 7, 2015

Conference proceedings

JOURNAL OF RHEUMATOLOGY

Issue

7

ISSN

0315-162X

Labels